openPR Logo
Press release

Kengreal Market Report by Valuates Reports

06-06-2019 01:42 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Latest Updates on Kengreal.

Cangrelor (trade name Kengreal in the US and Kengrexal in Europe) is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug[1] for intravenous application. Some P2Y12 inhibitors are used clinically as effective inhibitors of adenosine diphosphate-mediated platelet activation and aggregation.

"Kengreal Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Kengreal covering the historical global sales and also provides the Kengreal sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Kengreal and emerging therapies in this space.

View full Report: https://reports.valuates.com/sreport/DELV-DRIN-425/Kengreal_Drug_Insight_2019

Methodology

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope

• A review of the Kengreal, based on information derived from company and industry-specific sources
• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the Drug Master Files and API Manufacturers by country
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Forecasted Sales Figure from 2019-2021
• Market competition and emerging therapies
• SWOT Analysis

Inquire for Sample: https://reports.valuates.com/request/sample/DELV-DRIN-425/Kengreal_Drug_Insight_2019

Reasons to Buy

• Establish a comprehensive understanding of Kengreal
• Access to drug`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around drug`s patents for the major markets- US and EU
• Understand Kengreal`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for the drug
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
• Identify opportunities in the same area as Kengreal with DelveInsight`s SWOT analysis

Inquire for Discount: https://reports.valuates.com/request/discount/DELV-DRIN-425/Kengreal_Drug_Insight_2019

Valuates Reports
sales@valuates.com
For U.S. Toll Free Call +1 (425) 388-2538
For IST Call +91-8040957137

To know more visit us on:

Website: https://reports.valuates.com/
Linkedin: www.linkedin.com/company/valuatesreports
Facebook: www.facebook.com/valuatesreports
Twitter: www.twitter.com/valuatesreports
Instagram: www.instagram.com/reportsvaluates
Youtube: www.youtube.com/channel/UCH4wNXynaTZbiD5m92WQI4A

Our aim is to collate unparalleled Market insights and notify our customers as and when it happens. Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of silicon valley of India (Bengaluru) and provide 24/7 online and offline support to all our customers and just a phone call away.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kengreal Market Report by Valuates Reports here

News-ID: 1766754 • Views: 250

More Releases from Valuates Reports

Global Electric Vehicle (EV) Battery Market Size was Valued At $23 Billion in 20 …
Electric Vehicle Battery Market Statistics - 2025 A battery is used as a secondary power source in automobiles. An electric vehicle (EV) battery is a secondary (rechargeable) battery. It uses chemical energy stored in rechargeable battery packs for power and therefore does not require any combustion engine for propulsion. An electric vehicle battery or traction battery powers the propulsion of battery electric vehicles. In recent years, consumers are more inclined toward battery
3D Cell Culture Market Research Report : Market size, Market Forecast, Market Sh …
The global 3D Cell Culture market is valued at 510 million US$ in 2018 and will reach 1210 million US$ by the end of 2025, growing at a CAGR of 13.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the 3D Cell Culture market based on company, product type, end user and key regions. A 3D cell culture is an artificially-created environment in
Connected Car Market Report | Market size, Market Forecast, Market Share, Indust …
The Global Connected Car Market was valued at $63,026.0 million in 2017, and is projected to reach $225,158.0 million by 2025, registering a CAGR of 17.1% from 2018 to 2025. In 2017, North America garnered the highest share in the global connected car market. Connected car facilitates connectivity on wheels offering comfort, convenience, performance, safety, and security along with powerful network technology. This enables the driver to connect with online platforms,
Global Aircraft Engine market size will reach 57.28 Billion US$ by 2025, growing …
GLOBAL AIRCRAFT ENGINE MARKET TRENDS: The turbofan segment currently holds a significant share in the demand for aircraft engines and may continue to do so over the forecast period. Turbofan engines are most commonly used in the military and commercial sectors. New aircraft programs such as COMAC C919 and Boeing 777X, which are still in service, are powered by turbofan engines of the latest generation. “The global Aircraft Engine market will reach

All 5 Releases


More Releases for Kengreal

Antiplatelet Drugs Market Registering a Strong Growth by 2025
Antiplatelet drugs are wrongly referred to as the blood thinning drugs. They don’t thin the blood but instead interfere with the important process by which blood clots. Antiplatelet agent normally decrease the clumping of blood cells thereby decreasing the potentially harmful blood clots. People who are at high risk of heart disease when given antiplatelet agents, their risks of strokes and heart attacks can be avoided. Antiplatelet agents are widely used
Antiplatelet Drugs Market Significantly Expand During 2017 - 2025
Antiplatelet drugs are wrongly referred to as the blood thinning drugs. They don’t thin the blood but instead interfere with the important process by which blood clots. Antiplatelet agent normally decrease the clumping of blood cells thereby decreasing the potentially harmful blood clots. People who are at high risk of heart disease when given antiplatelet agents, their risks of strokes and heart attacks can be avoided. Antiplatelet agents are widely used
Antiplatelet Drugs Market Size to Expand Lucratively during 2017 - 2025
Antiplatelet drugs are wrongly referred to as the blood thinning drugs. They don’t thin the blood but instead interfere with the important process by which blood clots. Antiplatelet agent normally decrease the clumping of blood cells thereby decreasing the potentially harmful blood clots. People who are at high risk of heart disease when given antiplatelet agents, their risks of strokes and heart attacks can be avoided. Antiplatelet agents are widely used
Antiplatelet Drugs Market Foreseen to Grow Exponentially Over 2017 - 2025
Antiplatelet drugs are wrongly referred to as the blood thinning drugs. They don’t thin the blood but instead interfere with the important process by which blood clots. Antiplatelet agent normally decrease the clumping of blood cells thereby decreasing the potentially harmful blood clots. People who are at high risk of heart disease when given antiplatelet agents, their risks of strokes and heart attacks can be avoided. Antiplatelet agents are widely used